A randomized controlled trial (RCT) published in Psychological Medicine demonstrates a significant and clinically relevant reduction in ADHD symptoms in adults using the digital therapy "attexis." ...
First High-Quality Study to Explore A Carnivore-Style Diet in Managing Metabolic Health, WhichAffects Millions of AmericansOver one-third of U.S. adults – or 115.2 million Americans – are prediabetic, ...
Initial treatments are underway in randomized study of Acorn’s personalized autologous injectable for improving facial ...
A new ancillary study published in Nature Medicine shows that Centrum Silver may slow biological aging markers.
Among patients with rheumatoid arthritis-associated interstitial lung disease, there was no significant difference in the ...
Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial Patients with advanced lung cancer reporting at least moderate ...
An international, randomized, double-blind, placebo-controlled Phase III study—the largest of its kind for mpox—found that tecovirimat did not improve clinical outcomes for adults with clade II mpox ...
Hand-foot syndrome (HFS) is a dose-limiting side effect of capecitabine. Celecoxib prevents HFS by inhibiting cyclooxygenase-2 (COX-2) that is upregulated because of the underlying associated ...
NEW YORK, March 4 (Reuters) - UniQure's trial design for its gene therapy for Huntington's disease did not offer sufficient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results